Medscape
The cutting edge of treating solid tumors with cell therapies got notably sharper this year. First came the US Food and Drug Administration (FDA) approval in February 2024 of the tumor-infiltrating lymphocyte (TIL) therapy lifileucel in unresectable or metastatic melanoma that had progressed on prior immunotherapy…
Read More
How Cell Therapies Help Fight Solid Tumors
Thomas Mcnaught
22:22
The cutting edge of treating solid tumors with cell therapies got notably sharper this year. First came the US Food and Drug Administration (FDA) approval in February 2024 of the tumor-infiltrating lymphocyte (TIL) therapy lifileucel in unresectable or metastatic melanoma that had progressed on prior immunotherapy…
